Skip to main content

Microarray Data Analysis in Bioinformatics - From Data to Discovery

$299.00
Your guarantee:
30-day money-back guarantee — no questions asked
How you learn:
Self-paced • Lifetime updates
Who trusts this:
Trusted by professionals in 160+ countries
When you get access:
Course access is prepared after purchase and delivered via email
Toolkit Included:
Includes a practical, ready-to-use toolkit containing implementation templates, worksheets, checklists, and decision-support materials used to accelerate real-world application and reduce setup time.
Adding to cart… The item has been added

This curriculum spans the full lifecycle of a multi-workshop bioinformatics project, equivalent to an internal capability program for establishing end-to-end microarray analysis in a research organisation, from experimental design through regulatory-compliant data sharing.

Module 1: Experimental Design and Sample Selection for Microarray Studies

  • Determine appropriate sample size using power analysis based on expected effect size and biological variability in pilot data.
  • Select matched case-control pairs or randomized cohorts to minimize confounding in differential expression analysis.
  • Define inclusion and exclusion criteria for patient-derived samples considering comorbidities, medication use, and sample collection timing.
  • Balance batch effects by randomizing sample processing order across experimental groups.
  • Decide between one-color and two-color microarray platforms based on experimental goals and available reference samples.
  • Document metadata rigorously, including tissue preservation method, RNA extraction protocol, and patient demographics for reproducibility.
  • Integrate sex, age, and batch variables as covariates during design to enable downstream adjustment.
  • Plan replicate structure—technical vs biological—based on variance components estimated from prior studies.

Module 2: Microarray Platform Selection and Data Acquisition

  • Evaluate probe content coverage for target genes of interest across Affymetrix, Illumina, and Agilent platforms.
  • Compare probe design specificity and cross-hybridization risks using BLAST alignment against the reference genome.
  • Assess dynamic range and sensitivity of platforms for low-abundance transcripts in the tissue type under study.
  • Negotiate data format delivery (e.g., CEL files, IDAT files) with core facility to retain raw data access.
  • Validate scanner calibration logs and PMT settings to ensure signal linearity across arrays.
  • Implement checksum verification for data transfer from sequencing core to local storage.
  • Establish naming conventions for samples that encode experimental group, batch, and processing date.
  • Configure automated file ingestion pipelines to parse vendor-specific file structures upon receipt.

Module 3: Raw Data Preprocessing and Quality Control

  • Generate array-level QC metrics including mean intensity, background levels, and presence/absence calls.
  • Identify outlier arrays using PCA and hierarchical clustering on unnormalized data.
  • Apply RLE (Relative Log Expression) and NUSE (Normalized Unscaled Standard Errors) plots to detect hybridization artifacts.
  • Filter out probes with low detection p-values across more than 50% of samples.
  • Decide between RMA, MAS5, or GCRMA normalization based on background correction needs and platform type.
  • Remove probes overlapping known SNPs or repetitive genomic regions to reduce false signals.
  • Correct for spatial artifacts on arrays using image inspection tools like AffyPLM.
  • Document QC decisions in a standardized report for audit and replication.

Module 4: Normalization and Batch Effect Adjustment

  • Apply quantile normalization for one-color arrays while preserving inter-array comparability.
  • Use ComBat to adjust for known batch effects when batch is correlated with experimental condition.
  • Assess effectiveness of batch correction using PCA before and after adjustment.
  • Retain uncorrected data as backup in case overcorrection removes biological signal.
  • Apply frozen surrogate variable analysis (fSVA) to estimate and adjust for hidden confounders.
  • Validate normalization success with density plot alignment across arrays.
  • Compare limma’s normalizeBetweenArrays with alternative methods for multi-batch studies.
  • Exclude arrays with extreme GC-content bias post-normalization from downstream analysis.

Module 5: Differential Expression Analysis and Statistical Modeling

  • Fit linear models using limma with empirical Bayes moderation for small sample sizes.
  • Incorporate covariates such as age, sex, and batch into the design matrix to control confounding.
  • Define significance thresholds using adjusted p-values (FDR < 0.05) and fold-change cutoffs (|log2FC| > 1).
  • Validate model assumptions using residual plots and mean-variance trends.
  • Perform contrasts for multi-group designs (e.g., time-course or dose-response) using appropriate coefficient combinations.
  • Apply duplicate correlation adjustment for repeated measurements on the same subject.
  • Compare results from limma with edgeR or DESeq2 when working with log-transformed microarray data.
  • Flag genes with high variability across replicates for manual inspection of probe behavior.

Module 6: Functional Enrichment and Pathway Analysis

  • Select gene sets from MSigDB, Reactome, or KEGG based on biological relevance to the study domain.
  • Apply over-representation analysis (ORA) using Fisher’s exact test with proper background gene filtering.
  • Use GSEA (Gene Set Enrichment Analysis) to detect subtle coordinated changes in gene sets.
  • Adjust enrichment p-values for multiple testing across gene sets using FDR or Bonferroni.
  • Interpret leading-edge analysis in GSEA to identify core genes driving enrichment signals.
  • Validate pathway results against independent datasets or literature evidence.
  • Filter out broad or redundant gene sets (e.g., “regulation of cellular process”) to improve interpretability.
  • Generate reproducible enrichment reports using RMarkdown or Quarto with embedded visualizations.

Module 7: Data Integration with External Omics Datasets

  • Map microarray probe IDs to consistent gene symbols using up-to-date annotation packages (e.g., hugene11sttranscriptcluster.db).
  • Integrate microarray expression with TCGA RNA-seq data using cross-platform normalization methods.
  • Perform correlation analysis between gene expression and methylation or CNV data from the same cohort.
  • Use WGCNA to identify co-expression modules and correlate eigengenes with clinical traits.
  • Align sample identifiers across datasets using harmonized patient IDs and remove mismatches.
  • Address platform-specific biases when merging data from different microarray versions.
  • Apply cross-dataset batch correction only after confirming biological comparability of tissues.
  • Validate integrated findings using external validation cohorts from GEO or ArrayExpress.

Module 8: Visualization and Interpretation of Results

  • Generate publication-ready heatmaps with dendrograms using pheatmap or ComplexHeatmap.
  • Plot volcano plots with labeled significant genes and effect size thresholds.
  • Create interactive visualizations using plotly for exploratory analysis by collaborators.
  • Use gene expression trajectory plots for time-series or developmental studies.
  • Integrate pathway diagrams with expression data using tools like Pathview.
  • Ensure color palettes are colorblind-safe and printer-friendly for manuscript submission.
  • Display probe-level data alongside gene-level summaries to expose probe discordance.
  • Produce multi-panel figures that link differential expression, enrichment, and network results.

Module 9: Data Sharing, Reproducibility, and Regulatory Compliance

  • Deposit raw and processed data in GEO or ArrayExpress with MIAME-compliant metadata.
  • Version control analysis scripts using Git with descriptive commit messages and branching.
  • Containerize analysis pipelines using Docker to ensure computational reproducibility.
  • Obtain IRB approval for data sharing when patient-derived samples are involved.
  • De-identify clinical metadata according to HIPAA or GDPR standards before public release.
  • Archive intermediate data files with checksums to enable pipeline re-execution.
  • Use workflow managers like Snakemake or Nextflow to document data provenance.
  • Respond to data access requests with data use agreements when required by funding bodies.